News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
883,638 Results
Type
Article (88767)
Company Profile (816)
Press Release (794031)
Multimedia
Podcasts (237)
Webinars (35)
Section
Business (233587)
Career Advice (4162)
Deals (39987)
Drug Delivery (177)
Drug Development (91699)
Employer Resources (207)
FDA (18552)
Job Trends (17484)
News (398720)
Policy (40013)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3053)
Academic (2)
Accelerated approval (56)
ADA (49)
Adcomms (40)
Allergies (194)
Alliances (56989)
ALS (236)
Alzheimer's disease (1965)
Antibody-drug conjugate (ADC) (551)
Approvals (18889)
Artificial intelligence (864)
ASCO (345)
Autoimmune disease (357)
Automation (64)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (248)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (84)
Breast cancer (836)
Cancer (6546)
Cardiovascular disease (552)
Career advice (3597)
Career pathing (52)
CAR-T (384)
CDC (76)
Celiac Disease (3)
Cell therapy (1066)
Cervical cancer (54)
Clinical research (78965)
Collaboration (2358)
Company closure (8)
Compensation (1506)
Complete response letters (106)
COVID-19 (3040)
CRISPR (124)
C-suite (1278)
Cystic fibrosis (167)
Data (8645)
Decentralized trials (3)
Denatured (90)
Depression (192)
Dermatology (96)
Diabetes (702)
Diagnostics (7590)
Digital health (69)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (421)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (317)
Earnings (102479)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138615)
Executive appointments (1190)
FDA (22608)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (36)
Funding (1929)
Gene editing (270)
Generative AI (89)
Gene therapy (848)
GLP-1 (1284)
Government (5559)
Grass and pollen (8)
Guidances (419)
Healthcare (21258)
Hematology (198)
HIV (94)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (352)
Immuno-oncology (114)
Indications (204)
Infectious disease (3436)
Inflammatory bowel disease (241)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (319)
Interviews (821)
IPO (18000)
IRA (61)
Job creations (5208)
Job search strategy (2871)
JPM (73)
Kidney cancer (23)
Labor market (120)
Layoffs (685)
Leadership (53)
Legal (10171)
Liver cancer (110)
Longevity (37)
Lung cancer (872)
Lymphoma (463)
Machine learning (66)
Management (66)
Manufacturing (1217)
MASH (226)
Medical device (15272)
Medtech (15424)
Mergers & acquisitions (23280)
Metabolic disorders (1819)
mRNA (266)
Multiple sclerosis (204)
NASH (24)
Neurodegenerative disease (505)
Neuropsychiatric disorders (126)
Neuroscience (3705)
Neurotech (2)
NextGen: Class of 2026 (7715)
Non-profit (5145)
Now hiring (80)
Obesity (868)
Opinion (374)
Ovarian cancer (243)
Pain (283)
Pancreatic cancer (348)
Parkinson's disease (415)
Partnered (39)
Patents (651)
Patient recruitment (752)
Peanut (70)
People (67979)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24406)
Phase 2 (34297)
Phase 3 (25794)
Pipeline (9682)
Policy (397)
Postmarket research (3559)
Preclinical (10977)
Press Release (72)
Prostate cancer (345)
Psychedelics (68)
Radiopharmaceuticals (371)
Rare diseases (1259)
Real estate (7462)
Recruiting (81)
Regulatory (30363)
Reports (77)
Research institute (2769)
Resumes & cover letters (654)
Rett syndrome (42)
RNA editing (29)
RSV (98)
Schizophrenia (196)
Series A (325)
Series B (235)
Service/supplier (28)
Sickle cell disease (127)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4371)
State (2)
Stomach cancer (21)
Supply chain (146)
Tariffs (104)
The Weekly (144)
Vaccines (1305)
Venture capital (132)
Weight loss (596)
Women's health (139)
Worklife (24)
Date
Today (154)
Last 7 days (667)
Last 30 days (3408)
Last 365 days (33273)
2026 (16000)
2025 (33219)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (400)
Arkansas (16)
Asia (52280)
Australia (9190)
California (14337)
Canada (4003)
China (1567)
Colorado (616)
Connecticut (638)
Delaware (441)
Europe (120558)
Florida (2127)
Georgia (466)
Hawaii (4)
Idaho (70)
Illinois (1244)
India (102)
Indiana (663)
Iowa (25)
Japan (588)
Kansas (143)
Kentucky (56)
Louisiana (64)
Maine (89)
Maryland (1739)
Massachusetts (10487)
Michigan (422)
Minnesota (799)
Mississippi (7)
Missouri (164)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (92)
New Jersey (3800)
New Mexico (35)
New York (3770)
North Carolina (1932)
North Dakota (11)
Northern California (7126)
Ohio (449)
Oklahoma (26)
Oregon (55)
Pennsylvania (2828)
Puerto Rico (30)
Rhode Island (54)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5624)
Tennessee (227)
Texas (2336)
United States (51298)
Utah (426)
Vermont (1)
Virginia (363)
Washington D.C. (89)
Washington State (1177)
West Virginia (4)
Wisconsin (158)
Wyoming (2)
There are 883,638 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ethyreal Bio Emerges from Stealth with $101 Million in Financing to Advance ETHY-001, a Potentially Best-in-Class Anti-TSHR Antibody for Thyroid Eye Disease and Graves’ Disease
June 10, 2026
·
6 min read
Press Releases
Gain Therapeutics to Present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
June 10, 2026
·
3 min read
Press Releases
Ligand Announces 2026 Investor Day in New York City
June 10, 2026
·
1 min read
Press Releases
Immunic to Participate in Investor, Industry and Scientific Conferences in June 2026
June 10, 2026
·
6 min read
Press Releases
Bridge to Life Announces Oral Presentations at the 2026 Annual Meeting of the American Transplant Congress (ATC) in Boston, MA, June 20-24, 2026
June 10, 2026
·
4 min read
Press Releases
HERVolution Therapeutics Demonstrates Preclinical Proof-of-Concept for Insulin Sensitization Immune Therapy in Metabolic Disease and Announces Exclusive License Agreement with the University of Copenhagen
June 10, 2026
·
3 min read
Press Releases
Italfarmaco Announces Health Canada Acceptance and Priority Review of New Drug Submission for Givinostat as a Duchenne Muscular Dystrophy Treatment
June 10, 2026
·
7 min read
IPO
Update: Parabilis raises industry-record $670M IPO
Parabilis Medicines is joining the parade of biotechs going public, with one key difference—more money.
June 10, 2026
·
2 min read
·
Gabrielle Masson
Alzheimer’s disease
Lilly bets up to $1B+ with AlzeCure in search for next Alzheimer’s act
The star of the licensing agreement, a small-molecule gamma-secretase modulator, will help buff Eli Lilly’s position in Alzheimer’s disease, currently headlined by its anti-amyloid antibody Kisunla.
June 10, 2026
·
2 min read
·
Tristan Manalac
Podcast
ASCO wins from RevMed, Akeso/Summit, more; plus more Lilly and more China; ADA on deck
Improved survival on display at the American Society of Clinical Oncology (ASCO) in Chicago; Pfizer’s unusual pact with China’s Innovent highlights a new type of collaboration; Eli Lilly continues its nonstop deal streak, including with Chinese biotechs; and looking ahead to this weekend’s American Diabetes Association meeting.
June 10, 2026
·
2 min read
·
Jef Akst
1 of 88,364
Next
